Lv43
410 积分 2024-07-30 加入
Current status and future perspectives of FGF21 analogues in clinical trials
1小时前
待确认
FGF-based drug discovery: advances and challenges
1小时前
已完结
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
8天前
已完结
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
8天前
已完结
Pharmacokinetics and Pharmacodynamics of GalNAc‐Conjugated siRNAs
8天前
已完结
Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview
8天前
已完结
Mechanistic Pharmacokinetics and Pharmacodynamics of GalNAc-siRNA: Translational Model Involving Competitive Receptor-Mediated Disposition and RISC-Dependent Gene Silencing Applied to Givosiran
8天前
已完结
Outcomes of the European Federation of Pharmaceutical Industries and Associations Oligonucleotide Working Group Survey on Nonclinical Practices and Regulatory Expectations for Therapeutic Oligonucleotide Safety Assessment
8天前
已完结
Antisense technology: an overview and prospectus
8天前
已完结
The current state and future directions of RNAi-based therapeutics
8天前
已完结
皖公网安备34019202002308
